1984
DOI: 10.1016/0049-3848(84)90001-x
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of factor VIIIRAg-1. A method for use in the hyland laser nephelometer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1985
1985
1985
1985

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Fragmentation has been suggested to cause similar discepancies in the immunoas say of Factor Vili RAG by Laurell [4] com pared with RIA [5], or nephelometry [6], Whichever explanation is correct, the im portant fact to emerge from this work is that fibronectin is altered during processing and that immunoassay methods, particularly the Laurell immunoelectrophoresis technique, could overestimate the fibronectin content of the blood products used for the treatment of patients. Future work in this area may show that functional assays of fibronectin based on its biological activity and the bind ing characteristics of its molecular domains, will prove to be the only methods that can reliably predict the therapeutic effectiveness of fibronectin-rich products manufactured for therapeutic use.…”
Section: The Assay Of Fibronectin In Blood Productsmentioning
confidence: 82%
“…Fragmentation has been suggested to cause similar discepancies in the immunoas say of Factor Vili RAG by Laurell [4] com pared with RIA [5], or nephelometry [6], Whichever explanation is correct, the im portant fact to emerge from this work is that fibronectin is altered during processing and that immunoassay methods, particularly the Laurell immunoelectrophoresis technique, could overestimate the fibronectin content of the blood products used for the treatment of patients. Future work in this area may show that functional assays of fibronectin based on its biological activity and the bind ing characteristics of its molecular domains, will prove to be the only methods that can reliably predict the therapeutic effectiveness of fibronectin-rich products manufactured for therapeutic use.…”
Section: The Assay Of Fibronectin In Blood Productsmentioning
confidence: 82%